...
首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study.
【24h】

Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study.

机译:右房超速起搏在预防症状性阵发性房颤中的作用:一项多中心随机研究,PAF-PACE研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to assess if right atrial overdrive pacing can suppress symptomatic episodes of paroxysmal atrial fibrillation (PAF) in patients without bradyarrhythmias. Forty-two patients with frequent and symptomatic PAF without other pacing indication had a pacemaker implanted after a 4-week run-in period, during which the frequency of symptomatic PAF episodes and the mean heart rate were objectively documented. Depending on the mean heart rate recorded during run-in, the pacemaker was programmed in random order to right atrial AAI pacing at 10-19 beats/min > mean heart rate (medium overdrive [MO]), at 20-29 beats/min > mean heart rate (high overdrive [HO]) and to no pacing (OAO mode) for 4-12 weeks each using a crossover design. In the 35 patients who completed the protocol, the number of symptomatic episodes of PAF (>30-second duration) per week was significantly lower during MO pacing (median 0.88, P = 0.001, n = 35) and during HO pacing (median 0.75, P = 0.002, n = 20) than during OAO(median 2.02 and 2.04, respectively). There was no difference between MO and HO pacing in the 20 patients paced at both rates (0.97 vs 0.75, P = 0.33). Seven patients did not complete the protocol due to persistent atrial fibrillation (n = 4), angina pectoris requiring surgery (n = 1), and unwillingness to continue the study due to improvement (n = 1) or worsening (n = 1) of symptoms during the study periods. Right atrial overdrive pacing can reduce the number of symptomatic PAF episodes in patients with frequent and drug refractory PAF but without bradyarrhythmias.
机译:这项研究的目的是评估在没有心律失常的患者中,正确的心房超速起搏是否可以抑制阵发性房颤的症状发作。 42例频繁出现症状性PAF且无其他起搏迹象的患者在经过4周的磨合期后植入了起搏器,在此期间客观记录了症状性PAF发作的频率和平均心率。根据在跑步过程中记录的平均心率,将起搏器随机编程为以10-19次/分钟>平均心律(中等超速[MO])的心房AAI起搏速度,以20-29次/分钟>平均心率(超速[HO]高),并且使用交叉设计在4至12周内无起搏(OAO模式)。在完成方案的35例患者中,MO起搏期间(中位数为0.88,P = 0.001,n = 35)和HO起搏期间(中位数为0.75),每周有症状的PAF发作次数(> 30秒持续时间)显着降低。 ,P = 0.002,n = 20),而不是OAO(分别为2.02和2.04)。在这两种速率下起搏的20例患者中,MO和HO起搏之间无差异(0.97 vs 0.75,P = 0.33)。由于持续性房颤(n = 4),需要治疗的心绞痛(n = 1)和由于改善(n = 1)或恶化(n = 1)不愿意继续研究,有7名患者未完成方案研究期间的症状。右房超速起搏可减少患有频发性和难治性PAF但无心律失常的患者的症状性PAF发作次数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号